Profile
HealthQuest Capital is a growth equity firm based in Redwood City, California, founded in 2013. The firm is led by Garheng Kong and a team of 28 professionals, including 7 partners, with over 300 years of combined experience. HealthQuest Capital distinguishes itself by focusing on transformative healthcare investments that enhance patient outcomes and improve healthcare delivery efficiency.
The firm invests in sectors such as medical devices, diagnostics, digital health, health tech, SaaS, and life sciences. HealthQuest Capital typically participates in Series B rounds and focuses on investments within the United States. The firm manages approximately $2 billion across several funds, including HealthQuest Capital Fund I and HealthQuest Partners IV, L.P.
Notable investments by HealthQuest Capital include OrganOx - organ preservation devices, HistoSonics - therapeutic devices, Remedy Meds - enterprise systems in healthcare, Diana Health - clinics/outpatient services, and Clearsense - medical records systems.
Industry
HealthQuest Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
HealthQuest Capital Fund I
|
Venture Capital (VC)
|
Consumer Services (B2C)
Healthcare Services
Medical Devices
HealthTech
|
Seed
|
North America
|
$5-10 m
|
$110 M
|
August 2014
|
|
HealthQuest Partners II, L.P.
|
Venture Capital (VC)
|
Consumer Services (B2C)
Healthcare Services
Medical Devices
HealthTech
|
Seed
|
North America
|
$5-10 m
|
$225 M
|
March 2016
|
|
HealthQuest Ajax II SPV
|
Venture Capital (VC)
|
Consumer Services (B2C)
Healthcare Services
Medical Devices
HealthTech
|
Seed
|
North America
|
$5-10 m
|
$33 M
|
May 2019
|
|
HealthQuest Partners IV, L.P
|
Venture Capital (VC)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
HealthTech
|
Seed
|
North America
|
$5-10 m
|
$675 M
|
May 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.